{
  "report_rows": [
    {
      "kpi": "Q2 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.305B vs. cons $1.291B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 operating EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.616 vs. cons $0.609",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 net new patients",
      "prediction": "BEAT",
      "answer": "pred ~152.0K vs. cons 148.2K",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 revenue",
      "prediction": "UNCHANGED",
      "answer": "guide $5.16B-$5.25B vs. cons $5.224B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 operating margin",
      "prediction": "UNCHANGED",
      "answer": "guide 23.0%-23.5% vs. cons UNVERIFIED",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -4.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -6.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 implicit H2 revenue caution drives revisions lower",
  "day5_confidence": "LOW"
}